Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating hepatic intra-arterial ipilimumab in combination with intravenous nivolumab for advanced hepatocellular carcinoma i…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients [Phase 2]
A Phase 2 pilot study is evaluating cannabis oil in patients with untreatable hepatocellular carcinoma (liver cancer). The trial is currentl…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies [Phase 1]
Phase 1 clinical trial evaluating ablation in combination with lenvatinib and anti-PD-1 antibodies for hepatocellular carcinoma, currently r…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC [Phase 3]
Phase 3 trial comparing hepatic arterial infusion chemotherapy (HAIC) plus sorafenib versus transarterial chemoembolization (TACE) plus sora…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients [Phase 1, Phase 2]
This clinical trial update reports termination of the MGD013 monotherapy and MGD013 with brivanib dose escalation/expansion study in advance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers
This document outlines a Canadian prospective protocol to evaluate biomarkers for hepatocellular carcinoma surveillance in patients with cir…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma [Phase 2]
This clinical trial listing describes a Phase 2 neoadjuvant study of donafenib combined with sintilimab and hepatic arterial infusion chemot…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
This entry notes the completion of a clinical trial evaluating the safety and tolerability of lenvatinib in participants with advanced or un…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 study evaluating pembrolizumab in combination with bavituximab for advanced hepatocellular carcinoma, with results posted and the …
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. [Phase 1]
Phase 1 trial update for YE-NEO-001, NantBioScience's personalized neoepitope yeast vaccine, evaluating adjuvant immunotherapy to elicit T-c…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Long-term Management of Patients With Ruptured HCC
This entry provides an update on the long-term management of patients with ruptured hepatocellular carcinoma from a completed clinical trial…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer [Phase 1]
Phase 1 trial evaluating the addition of pembrolizumab to standard antiretroviral therapy in HIV-positive patients with cancer. The study ha…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients [Phase 2]
A Phase 2 clinical trial is evaluating sequential or upfront triple therapy with durvalumab, tremelimumab, and bevacizumab for non-resectabl…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy in combination with Adebrelimab and Bevacizumab for potentially res…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy [NA]
A clinical trial registry entry indicates ongoing recruitment for a study on transcutaneous electrical acupoint stimulation (TEAS) to manage…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab [Phase 2]
A Phase 2 trial is investigating adjuvant treatment with donafenib in combination with envafolimab for patients with a high risk of recurren…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating the combination of pembrolizumab and lenvatinib for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma
A completed clinical trial sponsored by Ente Ospedaliero Cantonale in Bellinzona compared robotic-assisted liver resection to laparoscopic l…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors [NA]
A terminated clinical trial evaluating LC Bead LUMI radiopaque embolic beads for detecting and characterizing hepatic tumor vascularity has …
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous Therapy [Phase 4]
A Phase 4 clinical trial is planned to evaluate donafenib in combination with immunotherapy and local therapy for unresectable hepatocellula…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma. [Phase 2]
Phase 2 trial investigating neoadjuvant intra-tumor double immunotherapy for hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab as neoadjuvant therapy for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) [Phase 1]
This update reports the completion of a Phase 1 study (DUET-3) evaluating XmAb23104 in patients with selected advanced solid tumors.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma [NA]
Clinical trial update evaluating safety and efficacy of selective intra-arterial Holmium-166 radiation therapy in combination with atezolizu…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: HCC Screening Using DNA Methylation Changes in ctDNA
A completed clinical trial evaluating hepatocellular carcinoma screening using DNA methylation changes in circulating tumor DNA; results wer…